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Abstract
Chronic excessive alcohol intoxications evoke cumulative damage to tissues and organs. We examined prefrontal cortex
(Brodmann’s area (BA) 9) from 20 human alcoholics and 20 age, gender, and postmortem delay matched control subjects. H
& E staining and light microscopy of prefrontal cortex tissue revealed a reduction in the levels of cytoskeleton surrounding
the nuclei of cortical and subcortical neurons, and a disruption of subcortical neuron patterning in alcoholic subjects. BA 9
tissue homogenisation and one dimensional polyacrylamide gel electrophoresis (PAGE) proteomics of cytosolic proteins
identified dramatic reductions in the protein levels of spectrin b II, and a- and b-tubulins in alcoholics, and these were
validated and quantitated by Western blotting. We detected a significant increase in a-tubulin acetylation in alcoholics, a
non-significant increase in isoaspartate protein damage, but a significant increase in protein isoaspartyl methyltransferase
protein levels, the enzyme that triggers isoaspartate damage repair in vivo. There was also a significant reduction in
proteasome activity in alcoholics. One dimensional PAGE of membrane-enriched fractions detected a reduction in b-spectrin
protein levels, and a significant increase in transmembranous a3 (catalytic) subunit of the Na+,K+-ATPase in alcoholic
subjects. However, control subjects retained stable oligomeric forms of a-subunit that were diminished in alcoholics. In
alcoholics, significant loss of cytosolic a- and b-tubulins were also seen in caudate nucleus, hippocampus and cerebellum,
but to different levels, indicative of brain regional susceptibility to alcohol-related damage. Collectively, these protein
changes provide a molecular basis for some of the neuronal and behavioural abnormalities attributed to alcoholics.
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Introduction
Chronic excessive alcohol consumption is a global healthcare
problem of epidemic proportion [1]. Alcoholics experience a
number of cognitive deficiencies such as learning and memory
deficits, impairment of decision making, and problems with motor
skills, as well as suffering behavioural changes that include anxiety
and depression [2,3]. These debilitating morbidities arise from the
cumulative effects of intoxication and alcohol withdrawal, and
may be further exacerbated by nutritional deficiencies such as
Wernicke-Korsakoff disorders [2–6].
Excessive alcohol consumption can result in a reduction of brain
weight, with regional brain atrophy [2,4,5]. The production of
toxic ethanol metabolites, and their post-translational modification
(PTM) and damage of cellular proteins is one of the proposed
mechanisms that contribute to neuronal damage [5,7–9].
The first toxic metabolite of ethanol, acetaldehyde, can form
adducts with the e-amino group of lysine residues, and it has been
suggested that these covalent modifications can disrupt the
function of proteins resulting in cellular injury [10]. One of the
major targets of acetaldehyde-mediated adduction is a-tubulin
[11], and site specific a-tubulin acetylation can influence
microtubule polymerisation [10,11]. Acetaldehyde-protein ad-
ducts have been detected within the white matter, frontal cortex,
midbrain, dentate gyrus, and cerebellum in ethanol-fed rats, and
in the frontal cortex and midbrain of an alcoholic [7–9].
Furthermore, alcohol metabolism may also trigger the production
of detrimental protein adducts from products of lipid peroxidation,
including 4-hydroxy-2-nonenal (4-HNE), that can bind tubulins
and trigger loss of microtubular structures via an increase in their
insolubility [12–14].
In liver, ethanol consumption also increases protein damage as
isoaspartate via the impact of ethanol on the methionine metabolic
pathway [15,16]. Ethanol consumption triggers a reduction in the
levels of the methyl donor S-adenosylmethionine (SAM), and an
increase in the levels of the metabolite S-adenosylhomocysteine
(SAH). This reduced SAM:SAH ratio inhibits the activity of many
methyltransferases including protein isoaspartyl methyltransferase
(PIMT), an enzyme that functions to trigger the repair of
isoaspartate damaged proteins [17–19]. However, it has yet to
be determined whether a similar mechanism of ethanol-induced
inhibition of PIMT and elevation of isoaspartate damage exists in
brain tissue.
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Regional brain alcohol-induced pathology may impact upon
motor-neuron function, and also influence cognitive behaviour. In
an attempt to assess protein damage within a brain region involved
in cognitive and social behaviour, we first examined postmortem
brain tissue from the prefrontal cortex (region BA 9) from 20
human alcoholics and 20 age, gender, and postmortem delay
matched control subjects. We compared control and alcoholic
neuronal tissue histology, and then employed protein profiling to
identify prominent neuronal tissue protein changes. An identifi-
cation of the major brain protein changes provided an insight into
structural damage in alcoholic’s brains, for which functional
deficits were extrapolated.
Materials and Methods
Human Brain Samples and Ethics Statement
The human postmortem samples used in this study belong to the
brain collection of the Neuropsychopharmacology Research Group
at the Department of Pharmacology of the University of the Basque
Country (UPV/EHU). (http://www.farmacologia.ehu.es/s0026-
home/en/contenidos/informacion/s0026_presentacion/en_farm/
presentacion.html).
Brain collection is registered in the National Biobank Register of
the Spanish Health Department with the number C.0000035
(https://biobancos.isciii.es/ListadoColecciones.aspx). Human
brains were obtained at autopsy from 20 alcoholic and 20 control
subjects in the Basque Institute of Legal Medicine, Bilbao, Spain.
Brain collection was developed in compliance with policies of
research and ethical review boards for postmortem brain studies
(Basque Institute of Legal Medicine, Bilbao). Spanish legislation at
the time of sample collection did not require written informed
consent from the next of kin for use of these postmortem samples in
research. Furthermore, the analysis of postmortem brain specimens is
not defined as human research by the United States Department
of Health and Health Services (DHHS) and Food and Drug
Administration (FDA) regulations.
The diagnosis of alcoholism was carried out according to the
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-
R, DSM-IV or DSM-IV-TR; American Psychiatric Association)
or International Classification of Diseases criteria (ICD-10; World
Health Organization). All diagnoses were established by clinicians
in charge of the patients prior to death. This group included 20
alcoholic subjects with no other diagnosed psychiatric disease.
Each alcoholic case was carefully matched for gender, age and
postmortem delay with a control subject who died by sudden and
violent cause with no antemortem history of any neurologic or
psychiatric disorder. Blood toxicological screening for alcohol and
psychotropic drugs was undertaken for each study participant.
Tables 1 and 2 summarise the demographic characteristics and the
drug history of the subjects included in the microscopy and
biochemical studies respectively. Samples from the BA 9 region
were macroscopically dissected at the time of autopsy and
processed according to the type of study. Brain samples from 10
case-control matched pairs were processed for microscopy, and
brain samples from another 10 matched case-control pairs
immediately frozen and stored at 280uC until required for
biochemical studies. For 5 pairs of BA9 samples used for
biochemical studies, additional participant brain tissue from the
caudate nucleus, hippocampus, and cerebellum were also
obtained.
Brain Tissue Sectioning and Microscopy
Brain tissues were cryosectioned to 8 mm thicknesses using a
Microm HM 550 cryostat, and then mounted onto glass slides and
stained with H & E. Brain tissue sections were imaged using a
Leica DM4000B light microscope fitted with a 100x/1.25NA,
50x/0.9NA, 20x/0.4NA or 10x/0.25NA N Plan objective lens.
Images were captured by a MicroPublisher 3.3RTV camera
(QImaging) controlled by OpenLab software (Improvision/
PerkinElmer). Regional image capture and analysis were under-
taken for all control and alcoholic samples, for which represen-
tative images from a control and alcoholic matched pair are
included as Figure 1.
Brain Tissue Homogenisation
Brain tissue samples (,100 mg) were homogenised at 4uC in 20
volumes of phosphate buffer (200 mM Na2HPO4, 40 mM
NaH2PO4, 1 mM EDTA, pH 7.4) containing protease inhibitor
cocktail (Sigma), using an Ultra-Turrax T8 homogeniser (IKA
Labortechnik, Germany). Homogenates were centrifuged at
5006g for 10 min at 4uC in a benchtop centrifuge to pellet the
nuclear fraction. The supernatant was then centrifuged at
21,3006g for 40 min at 4uC to produce a crude cytosolic
preparation. The pellet from this centrifugation, corresponding
to the plasma membrane enriched fraction, was resuspended in 10
volumes of the homogenisation buffer. Nuclear, cytosolic, and
membrane enriched fractions were flash-frozen and stored at
280uC until required. Protein concentration in cytosolic and
membrane fractions was determined by Lowry protein assay (DC,
BioRad, UK) using bovine serum albumin (BSA) as a protein
standard.
One Dimensional Polyacrylamide Gel Electrophoresis
(1D-PAGE)
Protein homogenate was separated on 10% Bis-Tris NuPAGE
Novex pre-cast gels (20 mg/gel lane) run with 2-(N-morpholi-
no)ethanesulfonic acid (MES) running buffer as described previ-
ously [17]. Resolved proteins were either stained with colloidal
Coomassie blue and then densitometry performed using an
Odyssey laser scanner (LI-COR Biosciences, Lincoln, NE), or
proteins electroblotted at 80 V for 2 hours to a polyvinylidene
difluoride (PVDF) (Millipore) membrane for Western blotting. All
protein homogenates were resolved 2–3 times by gel electropho-
resis, and differentially expressed proteins excised from gels and
identified by mass spectrometry. Similarly, protein extracts were
all resolved 2–3 times for Western blotting analysis, with
representative figures from protein staining and blotting experi-
ments included as Figures.
Matrix Assisted Laser-desorption Ionisation-time of Flight
(MALDI-TOF) Mass Spectrometry
Differentially stained proteins were excised from gels and
analysed by MALDI-TOF mass spectrometry using a Micromass
MALDI (Waters, UK) as described previously [20].
Liquid Chromatography and Tandem Mass Spectrometry
(LC MS/MS)
Tryptic peptides from excised protein bands were run on a
Waters QTOF2 hybrid quadrupole mass spectrometer incorpo-
rating an integrated capillary LC system as described previously
[17]. Further details detailing peptides identified by MALDI-TOF
mass spectrometry and LC MS/MS are included as Data S1.
Western (immuno) blotting: PVDF membranes were stained with
Coomassie blue (Safestain, Invitrogen), and then destained with
50% methanol (v/v), 10% acetic acid (v/v) to visualise proteins,
and ensure even protein transfer across the blot. Membranes were
then washed in phosphate buffered saline (PBS) containing 0.05%
Alcohol-Related Brain Damage in Humans
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(v/v) Tween 20 (PBS-T), blocked for 1 h at room temperature
with 5% (w/v) milk protein in wash buffer, and then incubated
overnight at 4uC with the primary antibody of interest in blocking
buffer. The antibodies used in this study were directed against the
following proteins, and at the dilutions specified: goat polyclonal to
spectrin b II (Santa Cruz, sc-7468) at 1:250; rabbit polyclonal to b-
tubulin (Santa Cruz, sc-9104) at 1:250; mouse monoclonal to a-
tubulin (Santa Cruz, sc-8035) at 1:250; mouse monoclonal to
acetylated a-tubulin (Santa Cruz, sc-23950) at 1:250; mouse
monoclonal to protein-L-isoaspartate O-methyltransferase (Santa
Cruz, sc-100977) at 1:500; rabbit polyclonal to actin (Santa Cruz,
sc-1616-R) at 1:1000; mouse monoclonal to the a1 catalytic
subunit of the Na+,K+-ATPase (Abcam, ab7671) at 1:500. A
mouse monoclonal antibody to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Abcam, ab8245) was used at 1:3000
as a gel loading control for cytosols, and rabbit polyclonal to actin
(Santa Cruz, sc-1616-R) at 1:1000 as a gel loading control for
membrane fractions. Blots were washed in PBS-T and then
incubated for 1 hour at room temperature with their correspond-
ing horseradish peroxidase conjugated anti-species secondary
antibody (polyclonal goat anti-rabbit, goat anti-mouse or rabbit
anti-goat immunoglobulins, all purchased from Dako, products
P0448, P0447, P0449 respectively) at 1:1000 dilution in PBS-T.
Antibody immunoreactivity was visualised using SuperSignal West
Pico Chemiluminescent substrate (Pierce) with the light generated
captured on CL-Xposure X-ray film (Pierce), or using a Chemi
Doc device (Bio-Rad). Films were densitometrically scanned using
a CanoScan LiDE 700F flatbed scanner (Canon), and the levels of
proteins quantified using the public domain image processing
program ImageJ, developed at the National Institutes of Health.
Alternatively, blots were quantified using QuantityOne software
intrinsic to the Chemi Doc charge-coupled device. The results are
expressed as GAPDH or actin normalised values. The mean signal
density for quantitation of control samples was set at 100% of
protein signal. Blots probed for multiple antibody analyses were
intermittently antibody stripped with stripping buffer (Restore,
Thermo Scientific) by shaking at 125 rpm at 50uC for 30 minutes.
Quantification of Isoaspartate Levels
The level of isoaspartate in control and alcoholic cytosolic
extracts was quantified based upon the method of Aswad and
Deight [21]. Protein extracts (100–200 mg of protein) were
incubated in a final reaction volume of 100 ml, containing
40 mM K-MES, pH 6.2, 20 mM S-Adenosyl-L-[3H-methyl]-
methionine (3H-SAM) (8250 dpm/pmol, final specific activity),
and 2 mM recombinant PIMT (Promega). Methylation reactions
were initiated by the addition of PIMT and incubation for 30
minutes at 30uC. Methylation was terminated by the addition of
1 ml of ice-cold 7% (w/v) trichloroacetic acid (TCA), and protein
precipitation on ice for 10 minutes. Protein precipitate was
retained by centrifugation for 5 minutes in a refrigerated
centrifuge (Eppendorf 5415R) at maximum speed (16 1006g).
The supernatant containing unincorporated 3H-SAM was re-
moved to waste, and then the precipitate washed with 100 ml of
Table 1. Demographic characteristics, postmortem delay (PMD), cause of death, and blood toxicological screening of the control
(C) and alcoholic (A) subjects analysed by light microscopy.
Case Gender (F/M) Age (years) PMD (hours) Cause of death Ethanol in blood (mg/ml) Other drugs in blood
C1 M 54 23 Fall 0 Flurazepam
C2 M 46 16 Heart failure 0 (2)
C3 F 72 12 Heart failure 0 Flecainidine
C4 F 52 20 Heart failure 0 (2)
C5 M 46 8 Aortic dissection 0 (2)
C6 F 38 18 Heart failure 0 Ibuprofen
C7 F 55 22 Fall 0 Anfetamine, nordiazepam
C8 M 59 20 Heart failure 0 (2)
C9 M 57 20 Heart failure 0 (2)
C10 M 46 16 Aortic dissection 0 zolpidem
Mean 4F, 6M 5263 1762
A1 M 68 15 Acute heart and respiratory failure 0 (2)
A2 M 49 10 Acute heart and respiratory failure 1.14 (2)
A3 F 71 16 Acute heart and respiratory failure 0 (2)
A4 F 54 7 Acute heart and respiratory failure 3.04 (2)
A5 M 60 6 Acute heart and respiratory failure 0 Paracetamol
A6 M 46 11 Hemorrhage 0 (2)
A7 F 44 11 Acute heart and respiratory failure 0 (2)
A8 F 46 19 Acute heart and respiratory failure 1.43 (2)
A9 M 56 26 Acute heart and respiratory failure 0 (2)
A10 M 57 17 Acute heart and respiratory failure 0 (2)
Mean 4F, 6M 5563 1462
doi:10.1371/journal.pone.0093586.t001
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88% (v/v) formic acid. One ml of 7% TCA was added and protein
precipitation performed as before. Precipitate was again collected
by centrifugation and extraneous unincorporated 3H-SAM
removed. The pellet was washed as previous with 100 ml of 88%
(v/v) formic acid, and then precipitation with 1 ml of 7% TCA
repeated. The protein precipitate was then solubilised in 100 ml of
0.5 M NaOH, 1% (v/v) methanol, 5% (v/v) Triton X-100, and
transferred to 10 ml of scintillant and counted for radioactivity
incorporation using a Packard Tri-Carb counter. Replicate assays
were performed for all assay points from which an average value of
radiolabel incorporation determined. Radiolabel incorporation
into brain extracts in the absence of PIMT addition, due to
endogenous methylation was subtracted from assay values.
Isoaspartate quantitation was performed on the 10 matched pairs
of control and alcoholic brains.
Proteasome Activity Assay
Control or alcoholic brain tissue was homogenised in a buffer of
20 mM Tris-HCl pH 7.5, 2 mM ATP, 5 mM MgCl2, 1 mM
DTT at 4uC. The homogenate was centrifuged at 10, 0006g to
pellet cellular debris, and the supernatant transferred to a fresh
eppendorf. Fifty mg of homogenate was assayed for proteolytic
Figure 1. Histological examination of prefrontal cortex neuronal cells from controls and alcoholics. Cortical pyramidal cells (upper two
panels), and subcortical neurons (lower two panels) of control and alcoholic tissue sections were visualised by light microscopy. White bar represents
50 mm for 10x, 10 mm for 50x, and 5 mm for 100x lenses. Examples of the differences in the cytoplasm surrounding the nuclei of cells from alcoholic or
control tissue sections have been marked with white arrows.
doi:10.1371/journal.pone.0093586.g001
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activity against N-succinnyl-Leu-Leu-Val-Tyr-7-amido-4-methyl-
coumarin by fluorimetry (excitation wavelength 360 nm, emission
wavelength 460 nm). Fluorescent assays were performed in
duplicate from which an average value was obtained.
Statistics
Statistical comparison between data means was performed using
a Student’s t-test using GraphPad Prism 4 software, with results
expressed as means 6 SEM. A p value of ,0.05 was regarded as
statistically significant.
Figure 2. Profiling of cytosolic proteins from the prefrontal cortex of control and alcoholic subjects. Control (C) or alcoholic (A)
prefrontal cortex cytosolic proteins were resolved by 1D PAGE and proteins stained with colloidal Coomassie. Alcoholic subjects displayed a
prominent reduction in the level of protein staining at protein bands of ,270 kDa and ,50 kDa (upper panel). Protein levels were visualized by
Western blotting (lower panel). Abbreviations: GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PIMT, protein-L-isoaspartate O-methyltrans-
ferase.
doi:10.1371/journal.pone.0093586.g002
Table 3. Mass spectrometry identification of differentially expressed proteins from the prefrontal cortex of control and alcoholic
subjects.
Protein MW
(kDa)
Cellular
localisation
MOWSE
score
Protein
identification
UniProtKB/
SwissProt entry Protein function
50 Cytosolic 133 a-tubulin Q71U361 Microtubule activity, cytoskeleton,
protein movement.
50 Cytosolic 159 b-2-tubulin Q9BVA1{ Microtubule activity, cytoskeleton,
protein movement.
270 Cytosolic & membrane
associated
345* b-spectrin Q01082 Cytoskeleton, protein movement.
112 Trans-membranous 724* a3-subunit of
Na+,K+-ATPase
P13637 Catalysis of ATP coupled to the exchange of sodium
ions and potassium ions across the plasma membrane.
1UniProtKB/SwissProt entry of a-1A-tubulin.
{UniProtKB/SwissProt entry of b-2B-tubulin.
*Values from LC-MS/MS.
doi:10.1371/journal.pone.0093586.t003
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Results
Histological Examination of Prefrontal Cortex Neuronal
Cells from Controls and Alcoholics
To assess the presence of structural changes within BA 9 tissue
that may arise from cumulative ethanol intoxications, we
examined cells within brain tissue slices from 10 alcoholics and
10 control subjects matched for age, gender and postmortem delay –
refer to Table 1. Light microscopy of cells within the cortical
pyramidal cell layers revealed that cells from alcoholics exhibited
disrupted cytoplasm surrounding their nuclei. These differences
were particularly evident with a 100x lens – refer to arrows in
Figure 1, upper two panels. An examination of subcortical neurons
within the white matter of the alcoholic brain tissue slices also
highlighted a reduction in the level of organised cytoplasm
surrounding the nuclei. Additionally, subcortical neurons from
alcoholics lacked the ordered parallel arrangement of cells seen
with control subjects. These differences were well distinguished
with a 50x lens – refer to arrows in Figure 1, lower two panels.
Profiling of Cytosolic Proteins from the Prefrontal Cortex
of Control and Alcoholic Subjects and Western Blotting
To investigate further the reduced and disorganised cytoplasm
or cytoskeleton observed for alcoholic brain tissue, we homoge-
nised BA 9 tissue from control and alcoholics and examined
protein profiles by 1D PAGE. Due to limited sample availability,
and to further validate this observation with more subjects, 1D
PAGE was performed with an additional population of 10
matched control and alcoholic subjects, the details of which are
listed in Table 2. Visual inspection of 1D PAGE protein profiling
of cytosolic proteins revealed only two major recurrent protein
level differences between control and alcoholic groups. There was
a prominent reduction in the level of an ,270 kDa protein and an
,50 kDa protein, and these changes were visible in all alcoholics
when compared to their control matched counterparts – refer to
Figure 2, upper section. Protein bands at these molecular weights
from six individuals were removed and proteins identified by mass
spectrometry. The ,270 kDa protein band was identified as
spectrin b II, and the ,50 kDa protein band identified as a
mixture of peptides from different forms of a-tubulin and
b-tubulin – refer to Table 3 and Data S1.
To validate and quantify this dramatic loss of the cytoskeletal
proteins b-spectrin, and a- and b- type tubulins specifically within
alcoholic brain tissue, we assessed their protein levels by Western
blotting – Figure 2 lower section. Western blot analyses confirmed
a significant 36% decrease in spectrin b II (p = 0.0002), significant
56% decrease in a-tubulin (p = 0.0017) and significant 83%
decrease in b-tubulin levels (p,0.0001) for the 10 alcoholic
subjects – Figure 3. The alcoholic subjects for which the level of
either a- or b-tubulins were below the Western blotting detection
threshold have been expressed as 100% protein loss. Cytosolic
GAPDH levels were stable throughout all control and alcoholic
subjects investigated and were used for protein normalisation.
The cellular cytoskeletal network is composed of microtubules,
intermediate filaments, and microfilaments. The major protein
constituent of microfilaments is actin, hence we also quantified
actin protein levels to determine if cytoskeletal loss was extended to
actin in microfilaments. Actin levels increased by 16% in alcoholic
subjects, but this was not significant – Figures 2 & 3.
Examination of Protein PTM and Damage in Control and
Alcoholic Brain Tissue
We investigated possible PTMs of tubulins that may have
contributed to an alteration of their cytosolic level, or that may
influence tubulin stability or turnover. We quantified the level of
acetylated a-tubulin in all cytosolic protein samples by Western
Figure 3. Quantification of protein level and activity differences between control and alcoholic subjects. Protein levels were quantified
by Western blotting, and the levels of isoaspartate protein damage and proteasome activity determined. For quantitation of the ratio of acetylated a-
tubulin to total a-tubulin, the figure is representative of those subjects that displayed visible total a-tubulin signal (6 of the 10 subjects assayed). For
marked significance: * = p,0.05, ** = p,0.01, *** = p,0.001. Abbreviations: PIMT, protein-L-isoaspartate O-methyltransferase.
doi:10.1371/journal.pone.0093586.g003
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Figure 4. Western blot of a- and b-tubulins in nuclear and membrane fractions from the prefrontal cortex of control and alcoholic
subjects. Control (C) or alcoholic (A) prefrontal cortex nuclear and membrane fractions were resolved by 1D PAGE and proteins Western blotted for
a- and b-tubulins.
doi:10.1371/journal.pone.0093586.g004
Figure 5. Profiling of membrane-fraction proteins from the prefrontal cortex of control and alcoholic subjects. Control (C) or alcoholic
(A) prefrontal cortex membrane fraction proteins were resolved by 1D PAGE and proteins stained with colloidal Coomassie. Alcoholic subjects
displayed a prominent reduction in the level of protein staining at a protein band of ,270 kDa and upregulation at ,112 kDa (upper panel). Protein
levels of transmembranous (,112 kDa) Na+,K+-ATPase a-subunit, and oligomeric forms of the a-subunit were visualized by Western blotting (middle
panel). The level of transmembranous a-subunit was quantified using actin for normalisation (lower panel). For marked significance: *** = p,0.001.
doi:10.1371/journal.pone.0093586.g005
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blotting with an antibody that specifically recognizes acetylated
Lysine-40– Figure 2. The relative proportion of acetylated a-
tubulin to total a-tubulin was quantified as a significant 56%
increase (p = 0.0094) for alcoholic subjects when compared to their
matched controls – Figure 3.
Secondly, a- and b-tubulins can accumulate isoaspartate
damage in vivo if PIMT activity is inhibited or removed
[17,22,23]. We quantified the levels of total isoaspartate protein
damage in the cytosolic proteins from control and alcoholic brains,
and also the levels of cytosolic PIMT enzyme by Western blotting
– Figures 2 & 3. There was a 9% increase in total cytosolic
isoaspartate levels within the alcoholic brains but this did not reach
significance. In contrast there was a significant 28% increase
(p=0.0438) in cytosolic PIMT protein levels in alcoholics. Due to
the relatively low total levels of isoaspartate within control or
alcoholic brains, an examination of the specific levels of
isoaspartate protein damage within a- and b-tubulins was not
undertaken.
The proteasome complex is responsible for the turnover of the
majority of cytosolic proteins including tubulins [24,25]. Hence we
also quantified proteasomal activity of brain tissue from the 10
control and 10 alcoholic subjects. There was a significant 25%
reduction in proteasomal activity in the alcoholic subjects
(p=0.0426) – refer to Figure 3.
We also examined the levels of a- and b-tubulin within nuclear
and membrane fractions to assess whether the reduced cytosolic
protein levels seen in alcoholics arose from protein translocation to
these other cellular compartments. After 1D PAGE and Western
blotting there were no significant changes in the levels of a- or b-
tubulins in the nuclear or membrane fractions of alcoholic brain
tissue when compared to control subjects – Figure 4. This
suggested that a and b-tubulin protein loss in the prefrontal cortex
of alcoholics was limited to the cytosol.
Profiling of Membrane-fraction Proteins from the
Prefrontal Cortex of Control and Alcoholic Subjects
One dimensional PAGE profiling of proteins from the
membrane fractions of control and alcoholic subjects resulted in
the detection of two visually prominent protein changes. There
was a reduction in the protein levels of an ,270 kDa protein in
alcoholic subjects, and an increase in the levels of a protein doublet
at ,112 kDa protein – Figure 5 upper panel. Protein bands at
these molecular weights from 5 control and 5 alcoholic subjects
were excised from gels and analysed by mass spectrometry. Similar
to the cytosolic protein analysis, the reduced ,270 kDa protein
Figure 6. Profiling of cytosolic proteins from the caudate nucleus, hippocampus and cerebellum of control and alcoholic subjects.
Control (C) or alcoholic (A) cytosolic proteins from caudate nucleus, hippocampus, and cerebellum were resolved by 1D PAGE and proteins stained
with colloidal Coomassie (upper panel). The positions of the,50 kDa a- and b-tubulin protein bands are marked with arrows. Cytosolic proteins were
Western blotted for a- and b-tubulin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (middle panel), and protein level changes quantified
using GAPDH for normalization (lower panel). For marked significance: * = p,0.05, ** = p,0.01, *** = p,0.001.
doi:10.1371/journal.pone.0093586.g006
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was identified as spectrin b II. Both protein doublet bands at
,112 kDa protein were identified as the a3 subunit of the
Na+,K+-ATPase – refer to Table 3, and Data S1.
In concurrence with the protein staining data for the Na+,K+-
ATPase a-subunit, Western blotting confirmed a broader immu-
noreactivity of monomeric, membrane-associated a-subunit in
alcoholic subjects; quantified as a combined 31% significant
increase (p = 0.0002). Western blotting also showed that oligomeric
forms of a-subunit present in control subjects were virtually absent
in alcoholics, suggesting a functional deficit in a-a oligomerisation
– Figure 5 middle and lower panels.
Profiling of Cytosolic Proteins from the Caudate Nucleus,
Hippocampus and Cerebellum of Control and Alcoholic
Subjects
We wanted to ascertain if loss of a- and b-tubulins in alcoholic
brains was a regional phenomenon restricted to the prefrontal
cortex. Thus for those brain regions for which we also had access
to additional tissues, we examined the levels of cytosolic a- and b-
tubulins within caudate nucleus, hippocampus, and cerebellum
from 5 matched pairs of control and alcoholic subjects (subject
details included in Table 2). Cytosolic proteins from each of the
brain regions were resolved by 1D PAGE and Western blotted
with the specific anti-a- and anti- b-tubulin antibodies – Figure 6
upper and middle panels.
Quantitation of Western blots showed a significant reduction in
the total levels of a- and b-tubulins in all brain regions, but the
level of reductions were region specific. There was a significant
30% decrease (p=0.0198) in a-tubulin and a significant 31%
decrease (p = 0.0081) in b-tubulin in the caudate nucleus. There
was a significant 50% (p = 0.0004) and 47% (p = 0.0054) decrease
in a- and b-tubulin respectively in the hippocampus, and a
significant 54% (p = 0.0044) and 36% (p = 0.0486) decrease in a-
and b-tubulin in the cerebellum. However, the prefrontal cortex
displayed the greatest reductions in a-tubulin (56% decrease,
p = 0.0002) and b-tubulin levels (84%, p,0.0001) – Figure 6 lower
panels.
Discussion
An examination of the molecular abnormalities that arise as a
consequence of cumulative ethanol intoxications will assist with an
understanding of the development of tissue pathology. In addition,
a characterisation of ethanol-induced molecular changes may also
provide an insight into the molecular adaptations associated with
tolerance, dependence, and an alcoholic’s behavioural abnormal-
ities. Collectively, research in this field will provide a basis for
targeted therapeutics that counter debilitating morbidity, and
lower the incidence of mortality.
We assessed alcohol-related neuronal tissue damage of the
prefrontal cortex using light microscopy, and were intrigued to see
clear histological distinction between cells of alcoholics and their
matched controls. This led us to undertake one dimensional
protein profiling of cytosolic proteins from alcoholics and controls
and we identified the major protein losses as that from a- and b-
tubulins, and spectrin b-chain.
Alpha and b-tubulins localise as heterodimers, and are major
components of microtubules. Microtubules are non-covalent
cytoskeletal polymers that provide a cellular protein network.
Microtubules influence cell shape, motility, and stability, and are
central to the functioning of countless cellular processes including
mitosis, and vesicular transport [26,27]. Microtubules exist as both
dynamic and stable polymers, with transitions between these states
in sub-populations of microtubules influenced by PTMs and
microtubule-associated proteins (MAPs) [26,27]. Hence the loss of
functional tubulins seen in the BA 9 tissue of alcoholics would be
expected to result in a disruption of the cytoskeletal network, and
impinge on the many cellular trafficking processes that are
tethered to the cytoskeletal architecture.
Similar to tubulins, spectrins are a family of proteins that are
major structural components of the cytoskeleton. Spectrins (as a
and b heterodimers) act as molecular scaffolds that associate with
the cytoplasmic surface of the plasma membrane, and form a
molecular lattice that links the plasma membrane to actin and the
microtubule cytoskeleton [28,29]. Spectrin functions include
maintenance of cell shape, and arrangement of transmembranous
proteins. Additionally, brain spectrins function in the association of
vesicles to the microtubular network, and influence synaptic vesicle
stabilization and release [28,30]. Hence the reduction in spectrin
levels seen with alcoholic subjects would also likely disrupt cellular
trafficking processes, and the triggering of synaptic neurotrans-
mission events.
Thus collectively, we propose that a reduction of the cytoskeletal
architecture provides a rationale for the profound differences in
the prefrontal cortex neuronal histology of alcoholics, and likely
contributes to the cognitive and learning impairments experienced
by alcoholics.
We next considered molecular mechanisms that could explain
the selective damage and loss of these cytoskeletal proteins in
alcoholics. Ethanol can be converted in the cytosol to acetaldehyde
via the action of alcohol dehydrogenase, and in brain this
conversion may also be undertaken by catalase and cytochrome
P450 enzymes [31]. Acetaldehyde is a reactive compound and
readily adducts a number of cytosolic proteins including tubulins
[10,11]. We detected an ,1.5-fold increase in the ratio of
acetylated a-tubulin to total a-tubulin in the alcoholics. Similarly,
an increase in the relative proportion of acetylated a-tubulin (to
total a-tubulin) within liver or liver cells as a consequence of
ethanol consumption or exposure has been reported [32]. In liver,
this increased a-tubulin acetylation influences microtubule hy-
perstabilisation and inertness, with an associated impairment of
protein trafficking [32,33], but at present the influence of ethanol
consumption on brain tubulin acetyltransferases or deacetylases,
and the functional consequences of increased tubulin acetylation
have not been determined.
Another potential source of ethanol-induced damage to a- and
b-tubulin could arise through an increase in their protein damage
as isoaspartate. We detected a 9% increase in total cytosolic
isoaspartate levels within the alcoholic brains, although this did not
reach significance. It is still feasible that isoaspartate levels may
increase significantly specifically within a- and b-tubulins, but
since the total levels of cellular isoaspartate were low, quantitation
of individual protein isoaspartate levels was not attempted.
An increase in isoaspartate protein damage in alcoholic subjects
could be countered by upregulation of cellular PIMT levels to
trigger isoaspartate repair. We detected a significant 28% increase
in cytosolic PIMT protein levels in alcoholic tissue. Similarly, a
proteomic study of synaptic proteome changes in the superior
frontal gyrus (SFG) and occipital cortex (OC) of control and
alcoholic postmortem tissue reported a significant 30% increase in
PIMT protein levels in the SFG and a 50% increase in PIMT
protein levels in the OC of alcoholic subjects [34]. The molecular
mechanism by which PIMT protein levels are elevated has yet to
be determined, and it will be of interest to establish if it reflects a
compensatory means to counter an increase in cellular stress and
isoaspartate protein damage.
The 26S proteasome complex is the predominant cellular
protease that target proteins for degradation after their prior
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ubiquitination [25]. Additionally, oxidised, modified and/or
damaged proteins may also be degraded by 20S proteasomes
directly [35,36]. Hence one possible mechanism to explain the loss
of these cytoskeletal proteins is that ethanol induces PTMs and
protein damage, and this triggers protein elimination by the
proteasome. However, when quantified there was a significant
25% fall in the proteasome activity of alcoholic tissue. Thus
although the proteasome may still target clearance of these
proteins, its global cellular activity was compromised in the brains
of alcoholics.
The reduced levels of cytosolic proteins did not reflect
translocation to either the nuclear or membrane fractions. Protein
profiling of the membrane fraction also demonstrated that spectrin
b II was present at a reduced level in the membrane-enriched
fraction from alcoholics. The membrane-associated a-subunit of
the Na+,K+-ATPase was visualised and evidenced as two protein
bands of similar molecular weight. Western blotting enabled us to
quantify a significant increase in the transmembranous level of the
a-subunit of the Na+,K+-ATPase, which presumably reflected
immunoreactivity of both bands of the protein doublet.
The Na+,K+-ATPase catalyses the hydrolysis of ATP coupled to
the asymmetric exchange of intracellular Na+ for extracellular K+
across the plasma membrane, and participates in generation and
maintenance of a membrane potential [37]. Native Na+,K+-
ATPase is heterotrimeric, composed of three subunits: a, b, and c.
The a-subunit is the catalytically active ion transporting subunit.
The a1 isoform is ubiquitously distributed, whereas the a3 isoform
is expressed in neurons [37,38].
Western blotting with the Na+,K+-ATPase a-subunit antibody
revealed that stable higher molecular weight (oligomeric) forms of
the a-subunit present in controls were absent (or just visible with
long Western blot exposures) in alcoholic subjects. The existence
of a-a oligomers that are resistant to SDS-PAGE conditions have
been documented by independent groups [39,40].
Ethanol exposure can partially inhibit Na+,K+-ATPase pump
activity in the cerebellum of rats, although the precise mechanism
for pump inhibition has yet to be defined [41]. Defective Na+,K+-
ATPase a-subunits result in a rapid-onset dystonia Parkinsonism,
and other behavioural and cognitive deficits [38,42–44]. Hence it
is provocative to postulate that alterations in a-subunit levels or
function and/or oligomerisation could also contribute to some of
the behavioural symptoms exhibited by alcoholics.
We also examined tissue from additional brain regions and
detected a significant reduction in a- and b-tubulin protein in the
caudate nucleus, hippocampus, and cerebellum, but not to the
levels of protein loss recorded for the prefrontal cortex. The
differential vulnerability of brain regions could reflect varied
penetrance across the blood brain barrier of the toxic metabolites
of ethanol, such as acetaldehyde and/or their specific regional
production.
Study Limitations
Although we have undertaken a quantitative evaluation of
protein levels using Western blotting we appreciate this is not
without methodological limitations. Antibody binding to a target
protein may be masked or sterically hindered due to the presence
of PTMs. This provides a rationale to explain why the antibody
directed against acetylated a-tubulin exhibited a higher immuno-
reactivity signal than the antibody directed against the full-length
a-tubulin protein – refer to Figure 2. Hence the total levels of
cytoskeletal protein degradation in alcoholic brain tissue are
clearly significant (and visibly prominent after 1D-PAGE and
protein staining), but levels of protein degradation may possibly be
overestimated using immunological reactivity.
Direct comparison with other proteomic studies of alcoholic
tissue from the prefrontal cortex is problematic due to differences
in alcoholic subject age, cumulative alcohol intake, as well as
variability of regional sampling, protein preparation and method-
ology etc [45–47]. Nevertheless, other independent two-dimen-
sional (2D) proteomic studies have also reported reductions in
alcoholic’s brains of the protein levels of a- and b-tubulins [45].
Within our study patients differ in many parameters such as blood
toxicology at death, but by matching each pair of controls and
alcoholics for age, gender, and postmortem delay, robust and
universal changes in protein levels and modifications were
revealed. A more substantive proteomic analysis by 2D separation
techniques may reveal additional protein level changes, however,
we were primarily concerned with prominent visual differences for
which a related function could be postulated; hence a compre-
hensive 2D-PAGE analysis was considered beyond the scope of
this primary publication. Furthermore, 2D proteomic studies
utilise protein fractionation and protein precipitation methods to
enrich components of the proteome for analyses [34,45–47], and
this could mask protein differences visible by primary 1D PAGE
screening.
An insight into changes within postmortem tissue of the frontal
cortex of alcoholic subjects has also been provided using gene
arrays [48–50]. These studies document numerous changes in
gene expression levels that include reduced expression of elements
of the ubiquitin-proteasome system in alcoholics [48–50], and
reduced expression of a beta III spectrin in cirrhotic alcoholics
[50]. Thus it remains likely that significant protein level changes
evidenced in the prefrontal cortex of alcoholic subjects arise from
alteration of transcriptional and translational mechanisms.
In summary, we report profound reductions in the levels of the
cytoskeletal proteins a- and b-tubulin, and spectrin b II in
alcoholic subjects that correlate with altered neuronal cell
organisation and cell patterning visible by light microscopy. The
known susceptibility of these proteins to protein damage or
regulatory PTMs provides a putative mechanism to explain their
targeted loss of protein level and function. Altered protein level
and PTMs of the cytoskeletal architecture, and also disruption of
the functional activity of the Na+,K+-ATPase provides a molecular
basis for some of the altered neuronal and behavioural manifes-
tations encountered by alcoholics, and may also contribute to the
atrophic brain macrostructure that is phenotypic of an alcoholic.
Supporting Information
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